Status:
COMPLETED
Analysis of Markers in the Blood Correlated With Neuropathic Pain
Lead Sponsor:
Christoph Stein, MD
Collaborating Sponsors:
deCODE genetics
Conditions:
Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to analyze associations between symptoms and specific markers in the blood in patients suffering from neuropathic pain linked to diseases of different origin. Such markers...
Detailed Description
On average, 3-8% of the German population suffers from neuropathic pain, which can occur after damage of somatosensory nerves in the peripheral or central nervous system. In terms of a "personalized" ...
Eligibility Criteria
Inclusion
- HIV-associated neuropathy
- Sufficient knowledge of the German language
Exclusion
- Co-incident severe central nervous system diseases
- Major psychiatric conditions
- Dementia
- Limited mental capacity or limited German language skills
- Intoxication with alcohol or recreational drugs within the last 48 hours of the study
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02208206
Start Date
July 1 2014
End Date
January 1 2019
Last Update
February 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Operative Intensive Care Medicine, Charité - Universitätsmedizin Berlin
Berlin, Germany, 12203